Chiquita Brooks-LaSure

And even in trying to get drug negotiation, there was just a lot of pressure and arguments that we're going to stifle innovation and just all of these all of these pressure points. But at the end of the day, what I firmly believe is the private sector is wise. It will figure out how to make money one way or another. It may be different than how it was, but the private sector will adjust.

And even in trying to get drug negotiation, there was just a lot of pressure and arguments that we're going to stifle innovation and just all of these all of these pressure points. But at the end of the day, what I firmly believe is the private sector is wise. It will figure out how to make money one way or another. It may be different than how it was, but the private sector will adjust.

And even in trying to get drug negotiation, there was just a lot of pressure and arguments that we're going to stifle innovation and just all of these all of these pressure points. But at the end of the day, what I firmly believe is the private sector is wise. It will figure out how to make money one way or another. It may be different than how it was, but the private sector will adjust.

It will continue to innovate. But if people can't afford their drugs, it's not going to matter. You know, there are these incredibly lifesaving things that are coming to market. But if people can't afford them, then you know, nobody's gonna actually be able to get them.

It will continue to innovate. But if people can't afford their drugs, it's not going to matter. You know, there are these incredibly lifesaving things that are coming to market. But if people can't afford them, then you know, nobody's gonna actually be able to get them.

It will continue to innovate. But if people can't afford their drugs, it's not going to matter. You know, there are these incredibly lifesaving things that are coming to market. But if people can't afford them, then you know, nobody's gonna actually be able to get them.

Well, just to say, It requires a lot of effort to pass legislation, and it requires even more effort to make that legislation come to life. And part of that is because when you're tackling something of this magnitude and this size, you really have to take in what... everyone's point of view and really make sure you have a good grasp of how's the industry gonna react?

Well, just to say, It requires a lot of effort to pass legislation, and it requires even more effort to make that legislation come to life. And part of that is because when you're tackling something of this magnitude and this size, you really have to take in what... everyone's point of view and really make sure you have a good grasp of how's the industry gonna react?

Well, just to say, It requires a lot of effort to pass legislation, and it requires even more effort to make that legislation come to life. And part of that is because when you're tackling something of this magnitude and this size, you really have to take in what... everyone's point of view and really make sure you have a good grasp of how's the industry gonna react?

How are we gonna make this happen? I mean, there's so many steps to figuring out how to make sure your great idea actually translates into when someone shows up at the pharmacy, they actually get the drug. And so the process of hammering out all those things is passing legislation, making the compromises that need to happen to get it through.

How are we gonna make this happen? I mean, there's so many steps to figuring out how to make sure your great idea actually translates into when someone shows up at the pharmacy, they actually get the drug. And so the process of hammering out all those things is passing legislation, making the compromises that need to happen to get it through.

How are we gonna make this happen? I mean, there's so many steps to figuring out how to make sure your great idea actually translates into when someone shows up at the pharmacy, they actually get the drug. And so the process of hammering out all those things is passing legislation, making the compromises that need to happen to get it through.

And certainly in implementation, hearing, there are always things that no matter how smart you are, how knowledgeable you are, that you have to hear perspectives. And during my time, I met with so many executives. And of course, not just me, just the team spent so much time hearing with all sorts of people across the chain to really figure out how do we make this happen?

And certainly in implementation, hearing, there are always things that no matter how smart you are, how knowledgeable you are, that you have to hear perspectives. And during my time, I met with so many executives. And of course, not just me, just the team spent so much time hearing with all sorts of people across the chain to really figure out how do we make this happen?

And certainly in implementation, hearing, there are always things that no matter how smart you are, how knowledgeable you are, that you have to hear perspectives. And during my time, I met with so many executives. And of course, not just me, just the team spent so much time hearing with all sorts of people across the chain to really figure out how do we make this happen?

And again, like things pop up where you realize, oh, I didn't know this about the supply chain because nobody ever did this before in the Medicare program. And I think that there is a frustration on a bipartisan basis that other countries seem to get way lower prices than we do on prescription drugs. They also have different systems.

And again, like things pop up where you realize, oh, I didn't know this about the supply chain because nobody ever did this before in the Medicare program. And I think that there is a frustration on a bipartisan basis that other countries seem to get way lower prices than we do on prescription drugs. They also have different systems.

And again, like things pop up where you realize, oh, I didn't know this about the supply chain because nobody ever did this before in the Medicare program. And I think that there is a frustration on a bipartisan basis that other countries seem to get way lower prices than we do on prescription drugs. They also have different systems.

I was talking to a group of people from another country who are all health executives, and I said, do you know what PBMs are? And they did not know what PBMs are, right? Like we do things a little differently here. And so that's not to say that we shouldn't care what other what other countries are getting.

I was talking to a group of people from another country who are all health executives, and I said, do you know what PBMs are? And they did not know what PBMs are, right? Like we do things a little differently here. And so that's not to say that we shouldn't care what other what other countries are getting.